Benzinga | Aug 6, 2020 04:01PM EDT

Axonics Modulation Tech Q2 EPS $(0.54) Beats $(0.67) Estimate, Sales $15.20M Beat $5.19M Estimate

Axonics Modulation Tech (NASDAQ:AXNX) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.67) by 19.4 percent. This is a 20.59 percent increase over losses of $(0.68) per share from the same period last year. The company reported quarterly sales of $15.20 million which beat the analyst consensus estimate of $5.19 million by 192.87 percent. This is a 921.51 percent increase over sales of $1.49 million the same period last year.